BLFS Q2 2021 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q2 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$31M+214.6% YoY

Gross Profit

$13M40.5% margin

Operating Income

-$5M-14.6% margin

Net Income

$8M25.2% margin

EPS (Diluted)

$0.19

QoQ Revenue Growth

+85.2%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$521M

Total Liabilities

$69M

Stockholders' Equity

$452M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$10M	+214.6%
Gross Profit	$13M	$5M	+133.4%
Operating Income	-$5M	$44,000	-10452.3%
Net Income	$8M	-$16M	+148.1%

Revenue Segments

Rental Revenue

$12M96%

Service Revenue

$563,0004%